BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 15337038)

  • 21. [Clinical significance of CEA levels in lung cancer].
    Noge S; Hara N; Ichinose Y; Ishimatsu T; Motohiro A; Etoh K; Miyake J; Ohta M
    Gan No Rinsho; 1985 May; 31(6 Suppl):616-22. PubMed ID: 2993691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical evaluation of tumor markers in head and neck squamous cell carcinomas].
    Yoneda K; Hirota J; Yamamoto T; Ueta E; Osaki T
    Gan No Rinsho; 1990 Mar; 36(4):458-64. PubMed ID: 2181163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tumor markers. I. Their significance in the preoperative assessment of lung neoplasms].
    Ratto GB; Capponi G; De Grandi R; Augeri C; Secco GB; Fardelli R
    Minerva Chir; 1990 Oct; 45(20):1265-72. PubMed ID: 1964495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma.
    Guadagni F; Roselli M; Amato T; Cosimelli M; Perri P; Casale V; Carlini M; Santoro E; Cavaliere R; Greiner JW
    Cancer Res; 1992 Mar; 52(5):1222-7. PubMed ID: 1737383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of pretreatment CEA, SCC-Ag and CA 19-9 levels in sera of patients with non-small cell lung cancer.
    Niklinski J; Furman M; Laudanski J; Kozlowski M
    Eur J Cancer Prev; 1992 Oct; 1(6):401-6. PubMed ID: 1334443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical evaluation of serum carbohydrate antigen 19-9 in carcinoma of the lung--a comparison with carcinoembryonic antigen].
    Hayashibe A; Kodama T; Nishiwaki Y; Kudou H; Inoue Y; Nukariya N; Kaguraoka H; Kuroki M; Takahashi K; Nishiyama Y
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):711-5. PubMed ID: 3030198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Measurement of carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific enolase in the bronchoalveolar lavage fluid in patients with peripheral lung cancer].
    Fujii M; Kiura K; Kamei H; Segawa Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Apr; 27(4):452-5. PubMed ID: 2552209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix.
    Hopkins MP; Morley GW
    Obstet Gynecol; 1991 Jun; 77(6):912-7. PubMed ID: 2030867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Serum neuron specific enolase (NSE) levels in patients with non small cell lung cancer].
    Shibayama T; Ohnoshi T; Ueoka H; Horiguchi T; Kodani T; Segawa Y; Maeda T; Miyatake K; Takigawa N; Kimura I
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jun; 30(6):1097-102. PubMed ID: 1324376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epidemiologic aspects of the histologic types of lung cancer].
    Wilde J; Matthäi C; Wilde J
    Z Erkr Atmungsorgane; 1990; 175(1):9-19. PubMed ID: 2171236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical evaluation of combination assay of tumor markers in primary lung cancer patients].
    Hatakeyama S; Nagai A; Kioi S; Arakawa M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Aug; 28(8):1053-8. PubMed ID: 2173801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of serum levels of beta2-microglobulin and carcino-embryonic antigen in the follow-up of lung cancer (author's transl)].
    Ardiet C; Gonthier R; Pasquet P; Lahneche B
    Pathol Biol (Paris); 1978 Sep; 26(6):355-7. PubMed ID: 83584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preoperative high CEA level in lung cancer patients: significant of measurement of serum CEA level among preoperative and postoperative course in long time observed patient].
    Takeo S; Hara N; Ohta M
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Jul; 40(7):1089-94. PubMed ID: 1506701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tumor markers. II. Their significance in the follow-up of patients after radical resection of lung neoplasms].
    Ratto GB; Capponi G; De Grandi R; Augeri C; Secco GB; Fardelli R
    Minerva Chir; 1990 Oct; 45(20):1273-80. PubMed ID: 2082204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of squamous cell carcinoma antigen (SCC-Ag) in the diagnosis and follow-up of patients with non-small cell lung carcinoma.
    Nikliński J; Furman M; Laudański J; Kozłowski M
    Neoplasma; 1992; 39(5):279-82. PubMed ID: 1331826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor cell type versus staging in the prognosis of carcinoma of the lung.
    Greenberg SD; Fraire AE; Kinner BM; Johnson EH
    Pathol Annu; 1987; 22 Pt 2():387-405. PubMed ID: 2825102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostic significance of carcinoembryonic antigen measurement in bronchial lavage fluids in bronchial carcinoma].
    Ma WL
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Dec; 13(6):349-50, 380-1. PubMed ID: 1964877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The simultaneous evaluation of serum NSE as a tumor marker in lung cancer compared with serum CEA--high sensitivity and specificity defined in the TP-FP curve].
    Shimizu K; Nose I; Koga T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):472-8. PubMed ID: 3006595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemistry in stage FIGO III cervical cancer: prognostic value of tumor associated antigens and intermediate filaments.
    Gitsch G; Kainz C; Kohlberger P; Schneider B; Danihel L; Koelbl H; Breitenecker G
    Anticancer Res; 1992; 12(6B):2017-9. PubMed ID: 1284198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical investigation of basic fetoprotein (BFP) and carcinoembryonic antigen (CEA) in stomach cancer and lung cancer].
    Kanda Y; Ishii M
    Gan No Rinsho; 1985 May; 31(6 Suppl):600-5. PubMed ID: 2411961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.